medicaid and glp 1 coverage get with 🚨 A new Medicare program could expand access to GLP -1 GLP-1 Weight-Loss Drug Demonstration Begins

Generation of L Cells in mouse and human small intestine organoids

Do not split crush, or chew

Carnosine competes with proteins for the binding sites they would occupy on sugar molecules

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers

Strategic Implications/Executive Takeaways Focus on Multi-Condition Solutions: As GLP-1 receptor agonists gain traction in treating both type 2 diabetes and obesity, companies should emphasize these dual benefits to capture a broader patient base

For patients seeking dual-compound therapy, GLP-Squared injection begins at $289/mo (or $249/mo on the 3-month plan)